The -514 C→T hepatic lipase promoter region polymorphism and plasma lipids: A meta-analysis

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 8, 2004, Pages 3858-3863

  Isaacs, Aaron ^a   Sayed Tabatabaei, Fakhredin A ^a   Njajou, Omer T ^a   Witteman, Jacqueline C M ^a   Van Duijn, Cornelia M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIVER TRIACYLGLYCEROL LIPASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; CYTOSINE; HEPATIC LIPASE, HUMAN; THYMINE; TRIACYLGLYCEROL LIPASE;

ALLELE; ARTICLE; CARBOHYDRATE METABOLISM; CHOLESTEROL BLOOD LEVEL; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME METABOLISM; ETHNOLOGY; GENDER; GENE DOSAGE; GENE FREQUENCY; GENOTYPE; HUMAN; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; PRIORITY JOURNAL; PROMOTER REGION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL; CLINICAL TRIAL; GENETICS; META ANALYSIS;

CYTOSINE; GENOTYPE; HUMANS; LIPASE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); THYMINE;

EID: 4043125932     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-0188     Document Type: Article

References (55)

1. Bensadoun A, Berryman DE 1996 Genetics and molecular biology of hepatic lipase. Curr Opin Lipidol 7:77-81
2. Perret B, Mabile L, Martinez L, Terce F, Barbaras R, Collet X 2002 Hepatic lipase: structure/function relationship, synthesis, and regulation. J Lipid Res 43:1163-1169
3. Deeb SS, Peng R 2000 The C-514T polymorphism in the human hepatic lipase gene promoter diminishes its activity. J Lipid Res 41:155-158
4. Cai SJ, Wong DM, Chen SH, Chan L 1989 Structure of the human hepatic triglyceride lipase gene. Biochemistry 28:8966-8971
5. Ameis D, Stahnke G, Kobayashi J, McLean J, Lee G, Buscher M, Schotz MC, Will H 1990 Isolation and characterization of the human hepatic lipase gene. J Biol Chem 265:6552-6555
6. Vega GL, Clark LT, Tang A, Marcovina S, Grundy SM, Cohen JC 1998 Hepatic lipase activity is lower in African American men than in white American men: effects of 5′ flanking polymorphism in the hepatic lipase gene (LIPC). J Lipid Res 39:228-232
7. Vega GL, Gao J, Bersot TP, Mahley RW, Verstraete R, Grundy SM, White A, Cohen JC 1998 The -514 polymorphism in the hepatic lipase gene (LIPC) does not influence androgen-mediated stimulation of hepatic lipase activity. J Lipid Res 39:1520-1524
8. Tahvanainen E, Syvanne M, Frick MH, Murtomaki-Repo S, Antikainen M, Kesaniemi YA, Kauma H, Pasternak A, Taskinen MR, Ehnholm C 1998 Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene. The LOCAT Study Invsestigators. J Clin Invest 101:956-960
9. Shohet RV, Vega GL, Anwar A, Cigarroa JE, Grundy SM, Cohen JC 1999 Hepatic lipase (LIPC) promoter polymorphism in men with coronary artery disease. Allele frequency and effects on hepatic lipase activity and plasma HDL-C concentrations. Arterioscler Thromb Vasc Biol 19:1975-1978
10. Nie L, Wang J, Clark LT, Tang A, Vega GL, Grundy SM, Cohen JC 1998 Body mass index and hepatic lipase gene (LIPC) polymorphism jointly influence postheparin plasma hepatic lipase activity. J Lipid Res 39:1127-1130
11. Jansen H, Verhoeven AJ, Weeks L, Kastelein JJ, Halley DJ, van den Ouweland A, Jukema JW, Seidell JC, Birkenhager JC 1997 Common C-to-T substitution at position -480 of the hepatic lipase promoter associated with a lowered lipase activity in coronary artery disease patients. Arterioscler Thromb Vasc Biol 17:2837-2842
12. Grundy SM, Vega GL, Otvos JD, Rainwater DL, Cohen JC 1999 Hepatic lipase activity influences high density lipoprotein subclass distribution in normotriglyceridemic men. Genetic and pharmacological evidence. J Lipid Res 40:229-234
13. Zambon A, Deeb SS, Brown BG, Hokanson JE, Brunzell JD 2001 Common hepatic lipase gene promoter variant determines clinical response to intensive lipid-lowering treatment. Circulation 103:792-798
14. Couture P, Otvos JD, Cupples LA, Lahoz C, Wilson PW, Schaefer EJ, Ordovas JM 2000 Association of the C-514T polymorphism in the hepatic lipase gene with variations in lipoprotein subclass profiles: The Framingham Offspring Study. Arterioscler Thromb Vasc Biol 20:815-822
15. Guerra R, Wang J, Grundy SM, Cohen JC 1997 A hepatic lipase (LIPC) allele associated with high plasma concentrations of high density lipoprotein cholesterol. Proc Natl Acad Sci USA 94:4532-4537
16. Hubacek JA, Waterworth DM, Pitha J, Humphries SE, Talmud PJ, Poledne R 2001 Polymorphisms in the lipoprotein lipase and hepatic lipase genes and plasma lipid values in the Czech population. Physiol Res 50:345-351
17. Jansen H, Chu G, Ehnholm C, Dallongeville J, Nicaud V, Talmud PJ 1999 The T allele of the hepatic lipase promoter variant C-480T is associated with increased fasting lipids and HDL and increased preprandial and postprandial LpCIII:B: European Atherosclerosis Research Study (EARS) II. Arterioscler Thromb Vasc Biol 19:303-308
18. Murtomaki S, Tahvanainen E, Antikainen M, Tiret L, Nicaud V, Jansen H, Ehnholm C 1997 Hepatic lipase gene polymorphisms influence plasma HDL levels. Results from Finnish EARS participants. European Atherosclerosis Research Study. Arterioscler Thromb Vasc Biol 17:1879-1884
19. Ordovas JM, Corella D, Demissie S, Cupples LA, Couture P, Coltell O, Wilson PW, Schaefer EJ, Tucker KL 2002 Dietary fat intake determines the effect of a common polymorphism in the hepatic lipase gene promoter on high-density lipoprotein metabolism: evidence of a strong dose effect in this gene-nutrient interaction in the Framingham Study. Circulation 106:2315-2321
20. Yamakawa-Kobayashi K, Somekawa Y, Fujimura M, Tomura S, Arinami T, Hamaguchi H 2002 Relation of the -514C/T polymorphism in the hepatic lipase gene to serum HDL and LDL cholesterol levels in postmenopausal women under hormone replacement therapy. Atherosclerosis 162:17-21
21. Zambon A, Deeb SS, Pauletto P, Crepaldi G, Brunzell JD 2003 Hepatic lipase: a marker for cardiovascular disease risk and response to therapy. Curr Opin Lipidol 14:179-189
22. Chen W, Srinivasan SR, Boerwinkle E, Berenson GS 2003 Hepatic lipase promoter C-514T polymorphism influences serial changes in HDL cholesterol levels since childhood: the Bogalusa Heart Study. Atherosclerosis 169:175-182
23. Ji J, Herbison CE, Mamotte CD, Burke V, Taylor RR, van Bockxmeer FM 2002 Hepatic lipase gene -514 C/T polymorphism and premature coronary heart disease. J Cardiovasc Risk 9:105-113
24. Ko YL, Hsu LA, Hsu KH, Ko YH, Lee YS 2004 The interactive effects of hepatic lipase gene promoter polymorphisms with sex and obesity on high-density-lipoprotein cholesterol levels in Taiwanese-Chinese. Atherosclerosis 172:135-142
25. Carr MC, Ayyobi AF, Murdoch SJ, Deeb SS, Brunzell JD 2002 Contribution of hepatic lipase, lipoprotein lipase, and cholesteryl ester transfer protein to LDL and HDL heterogeneity in healthy women. Arterioscler Thromb Vasc Biol 22:667-673
26. Fang DZ, Liu BW 2002 Polymorphism of HL +1075C, but not -480T, is associated with plasma high density lipoprotein cholesterol and apolipoprotein AI in men of a Chinese population. Atherosclerosis 161:417-424
27. Hegele RA, Harris SB, Brunt JH, Young TK, Hanley AJ, Zinman B, Connelly PW 1999 Absence of association between genetic variation in the LIPC gene promoter and plasma lipoproteins in three Canadian populations. Atherosclerosis 146:153-160
28. Juo SH, Han Z, Smith JD, Colangelo L, Liu K 2001 Promoter polymorphisms of hepatic lipase gene influence HDL(2) but not HDL(3) in African American men: CARDIA study. J Lipid Res 42:258-264
29. Hong SH, Song J, Kim JQ 2000 Genetic variations of the hepatic lipase gene in Korean patients with coronary artery disease. Clin Biochem 33:291-296
30. St-Pierre J, Miller-Felix I, Paradis ME, Bergeron J, Lamarche B, Despres JP, Gaudet D, Vohl MC 2003 Visceral obesity attenuates the effect of the hepatic lipase -514C→T polymorphism on plasma HDL-cholesterol levels in French-Canadian men. Mol Genet Metab 78:31-36
31. van Duijn CM, Porta M 2003 Good prospects for genetic and molecular epidemiologic studies in the European Journal of Epidemiology. Eur J Epidemiol 18:285-286
32. Tan KC, Shiu SW, Chu BY 2001 Effects of gender, hepatic lipase gene polymorphism and type 2 diabetes mellitus on hepatic lipase activity in Chinese. Atherosclerosis 157:233-239
33. Arai Y, Hirose N, Yamamura K, Nakazawa S, Shimizu K, Takayama M, Ebihara Y, Homma S, Gondo Y, Masui Y, Inagaki H 2003 Deficiency of choresteryl ester transfer protein and gene polymorphisms of lipoprotein lipase and hepatic lipase are not associated with longevity. J Mol Med 81:102-109
34. Dugi KA, Brandauer K, Schmidt N, Nau B, Schneider JG, Mentz S, Keiper T, Schaefer JR, Meissner C, Kather H, Bahner ML, Fiehn W, Kreuzer J 2001 Low hepatic lipase activity is a novel risk factor for coronary artery disease. Circulation 104:3057-3062
35. Knoblauch H, Bauerfeind A, Krahenbuhl C, Daury A, Rohde K, Bejanin S, Essioux L, Schuster H, Luft FC, Reich JG 2002 Common haplotypes in five genes influence genetic variance of LDL and HDL cholesterol in the general population. Hum Mol Genet 11:1477-1485
36. Inazu A, Nishimura Y, Terada Y, Mabuchi H 2001 Effects of hepatic lipase gene promoter nucleotide variations on serum HDL cholesterol concentration in the general Japanese population. J Hum Genet 46:172-177
37. Park KW, Choi JH, Chae IH, Cho HJ, Oh S, Kim HS, Lee MM, Park YB, Choi YS 2003 Hepatic lipase C514T polymorphism and its relationship with plasma HDL-C levels and coronary artery disease in Koreans. J Biochem Mol Biol 36:237-242
38. Su ZG, Zhang SZ, Hou YP, Zhang L, Huang DJ, Liao LC, Xiao CY 2002 Relationship between a novel polymorphism of hepatic lipase gene and coronary artery disease. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao 34:780-785
39. Fan Y, Laaksonen R, Janatuinen T, Vesalainen R, Nuutila P, Koivula T, Knuuti J, Lehtimaki T 2001 Hepatic lipase gene variation is related to coronary reactivity in healthy young men. Eur J Clin Invest 31:574-580
40. Hokanson JE, Cheng S, Snell-Bergeon JK, Fijal BA, Grow MA, Hung C, Erlich HA, Ehrlich J, Eckel RH, Rewers M 2002 A common promoter polymorphism in the hepatic lipase gene (LIPC-480C→T) is associated with an increase in coronary calcification in type 1 diabetes. Diabetes 51:1208-1213
41. De Oliveira e Silva ER, Kong M, Han Z, Starr C, Kass EM, Juo SH, Foster D, Dansky HM, Merkel M, Cundey K, Brinton EA, Breslow JL, Smith JD 1999 Metabolic and genetic determinants of HDL metabolism and hepatic lipase activity in normolipidemic females. J Lipid Res 40:1211-1221
42. Shohet RV, Vega GL, Bersot TP, Mahley RW, Grundy SM, Guerra R, Cohen JC 2002 Sources of variability in genetic association studies: insights from the analysis of hepatic lipase (LIPC). Hum Mutat 19:536-542
43. Berk P, II, Hoogerbrugge N, Stolk RP, Bootsma AH, Jansen H 2003 Atorvastatin dose-dependently decreases hepatic lipase activity in type 2 diabetes: effect of sex and the LIPC promoter variant. Diabetes Care 26:427-432
44. Faggin E, Zambon A, Puato M, Deeb SS, Bertocco S, Sartore S, Crepaldi G, Pessina AC, Pauletto P 2002 Association between the -514 C→T polymorphism of the hepatic lipase gene promoter and unstable carotid plaque in patients with severe carotid artery stenosis. J Am Coll Cardiol 40:1059-1066
45. Talmud PJ, Berglund L, Hawe EM, Waterworth DM, Isasi CR, Deckelbaum RE, Starc T, Ginsberg HN, Humphries SE, Shea S 2001 Age-related effects of genetic variation on lipid levels: The Columbia University BioMarkers Study. Pediatrics 108:E50
46. Jansen H, Waterworth DM, Nicaud V, Ehnholm C, Talmud PJ 2001 Interaction of the common apolipoprotein C-III (APOC3-482C→T) and hepatic lipase (LIPC -514C→T) promoter variants affects glucose tolerance in young adults. European Atherosclerosis Research Study II (EARS-II). Ann Hum Genet 65:237-243
47. Hokanson JE, Kamboh MI, Scarboro S, Eckel RH, Hamman RF 2003 Effects of the hepatic lipase gene and physical activity on coronary heart disease risk. Am J Epidemiol 158:836-843
48. Allayee H, Dominguez KM, Aouizerat BE, Krauss RM, Rotter JI, Lu J, Cantor RM, de Bruin TW, Lusis AJ 2000 Contribution of the hepatic lipase gene to the atherogenic lipoprotein phenotype in familial combined hyperlipidemia. J Lipid Res 41:245-252
49. 447 stop variant of the lipoprotein lipase gene and C-514T variant of the hepatic lipase gene on serum triglyceride levels in young adults: the Bogalusa Heart Study. Metabolism 52:1337-1342
50. Carr MC, Hokanson JE, Zambon A, Deeb SS, Barrett PH, Purnell JQ, Brunzell JD 2001 The contribution of intraabdominal fat to gender differences in hepatic lipase activity and low/high density lipoprotein heterogeneity. J Clin Endocrinol Metab 86:2831-2837
51. Nie L, Niu S, Vega GL, Clark LT, Tang A, Grundy SM, Cohen JC 1998 Three polymorphisms associated with low hepatic lipase activity are common in African Americans. J Lipid Res 39:1900-1903
52. Kimura H, Miyazaki R, Imura T, Masunaga S, Suzuki S, Gejyo F, Yoshida H 2003 Hepatic lipase mutation may reduce vascular disease prevalence in hemodialysis patients with high CETP levels. Kidney Int 64:1829-1837
53. Anderson JL, Carlquist JF 2003 Genetic polymorphisms of hepatic lipase and cholesteryl ester transfer protein, intermediate phenotypes, and coronary risk: do they add up yet? J Am Coll Cardiol 41:1990-1993
54. Somekawa Y, Umeki H, Kobayashi K, Tomura S, Aso T, Hamaguchi H 2002 Effects of hormone replacement therapy and hepatic lipase polymorphism on serum lipid profiles in postmenopausal Japanese women. J Clin Endocrinol Metab 87:4766-4770
55. DerSimonian R, Laird N 1986 Meta-analysis in clinical trials. Control Clin Trials 7:177-188